We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Lindblad Expeditions
LIND
$2.22B
| $1.92M | ﹤0.01% |
206,254
-9,380
| -4% | -$86.4K |
|
1477
Heartland Express
HTLD
$956M
| $1.92M | ﹤0.01% |
160,853
+9,963
| +7% | +$127K |
|
1478
Interface
TILE
$2.22B
| $1.92M | ﹤0.01% |
114,118
-73,251
| -39% | -$1.01M |
|
|
VSTO
1479
DELISTED
Vista Outdoor Inc.
VSTO
| $1.92M | ﹤0.01% |
58,491
+35,591
| +155% | +$1.08M |
|
1480
Paymentus
PAY
$4.86B
| $1.91M | ﹤0.01% |
84,052
+38,387
| +84% | +$692K |
|
|
KYNB
1481
Kyntra Bio
KYNB
$29.4M
| $1.9M | ﹤0.01% |
32,411
-51,640
| -61% | -$2.22M |
|
1482
Universal Corp
UVV
$1.27B
| $1.9M | ﹤0.01% |
36,794
+22,614
| +159% | +$1.23M |
|
|
AAT
1483
American Assets Trust
AAT
$1.4B
| $1.9M | ﹤0.01% |
86,559
-1,132
| -1% | -$25K |
|
1484
Regenxbio
RGNX
$708M
| $1.9M | ﹤0.01% |
89,984
-25,087
| -22% | -$446K |
|
1485
Destination XL Group
DXLG
$35.4M
| $1.89M | ﹤0.01% |
525,423
+11,686
| +2% | +$45.8K |
|
1486
LiveRamp
RAMP
$2.3B
| $1.89M | ﹤0.01% |
54,763
-143,749
| -72% | -$5.28M |
|
1487
Teva Pharmaceuticals
TEVA
$41.2B
| $1.89M | ﹤0.01% |
133,749
-17,951
| -12% | -$226K |
|
|
LOVE
1488
LoveSac
LOVE
$261M
| $1.88M | ﹤0.01% |
83,237
-7,432
| -8% | -$173K |
|
1489
Utah Medical Products
UTMD
$225M
| $1.88M | ﹤0.01% |
26,450
+18,943
| +252% | +$1.42M |
|
1490
First Interstate BancSystem
FIBK
$3.58B
| $1.88M | ﹤0.01% |
+68,972
| New | +$1.88M |
|
1491
Ennis
EBF
$564M
| $1.88M | ﹤0.01% |
91,452
+29,404
| +47% | +$600K |
|
1492
Omnicell
OMCL
$1.68B
| $1.87M | ﹤0.01% |
+64,132
| New | +$1.94M |
|
1493
Vivid Seats
SEAT
$85.4M
| $1.87M | ﹤0.01% |
15,642
-13,057
| -45% | -$1.53M |
|
1494
Comstock Resources
CRK
$3.94B
| $1.87M | ﹤0.01% |
+201,894
| New | +$1.66M |
|
1495
Excelerate Energy
EE
$1.11B
| $1.87M | ﹤0.01% |
116,708
+6,206
| +6% | +$93K |
|
1496
Align Technology
ALGN
$12.3B
| $1.87M | ﹤0.01% |
5,700
-2,400
| -30% | -$704K |
|
1497
Burlington
BURL
$23.2B
| $1.87M | ﹤0.01% |
8,040
| – | – |
|
1498
Hilltop Holdings
HTH
$2.24B
| $1.86M | ﹤0.01% |
+59,449
| New | +$1.89M |
|
1499
Evolus
EOLS
$501M
| $1.86M | ﹤0.01% |
132,751
+6,297
| +5% | +$81.8K |
|
1500
Inter&Co
INTR
$2.33B
| $1.86M | ﹤0.01% |
325,482
+226,525
| +229% | +$1.24M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.